Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Surveys and Questionnaires × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Depression 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Support of the Family as a Caregiving System 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Peripheral Arterial Disease 1 Ovarian Neoplasms 1 Obesity 1 Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver 1 Neoplasms 1 Motor Activity 1 Melanoma 1 Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia 1 Laryngeal Diseases 1

Interventions

pembrolizumab 20 Specimen Handling 12 Paclitaxel 11 Magnetic Resonance Spectroscopy 11 Carboplatin 11 Biopsy 10 olaparib 7 Gemcitabine 5 Capecitabine 5 130-nm albumin-bound paclitaxel 5 eribulin 4 Taxes 4 Doxorubicin 4 X-Rays 3 Nivolumab 3 Cyclophosphamide 3 Cisplatin 3 tucatinib 2 sargramostim 2 liposomal doxorubicin 2 durvalumab 2 ceralasertib 2 Trastuzumab 2 Standard of Care 2 Platinum 2 Immunoglobulin G 2 Fulvestrant 2 Drug Therapy 2 Docetaxel 2 Colony-Stimulating Factors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡